2018-08-03 07:33:00 Fri ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
President Trump escalates the current Sino-American trade war by imposing 25% tariffs on $200 billion Chinese imports. These tariffs encompass chemical products, steel-and-aluminum goods, and other consumer goods from pet food and furniture to car tires, bicycles, baseball gloves, and beauty products. Commerce Secretary Willbur Ross points out that these non-cataclysmic tariffs amount to less than 1% of China's real GDP economic growth. In response, China prepares to retaliate by introducing 5%-25% tariffs on about $60 billion U.S. exports.
China's chief diplomat suggests that any U.S. unilateral threat or blackmail will only intensify Sino-U.S. trade conflicts with severe damage to the economic interests of all parties. Among other trade tools, the Trump administration now applies tariffs and duties to push China to abandon unfair practices in order to reach a new trade deal. The Trump team aims to balance its desire to force the Xi administration back to the negotiating table with joint efforts to avoid escalation in the current Sino-U.S. trade war. U.S. trade reps urge China to address the longstanding U.S. Trade Act Section 301 concerns about Chinese unfair practices such as patent, copyright, and trademark infringement and other intellectual property theft.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-01-07 18:42:00 Monday ET

Neoliberal public choice continues to spin national taxation and several other forms of government intervention. The key post-crisis consensus focuses on go
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-10-03 17:39:00 Thursday ET

President Trump indicates that he would consider an interim Sino-American trade deal in lieu of a full trade agreement. The Trump administration defers high
2017-07-01 08:40:00 Saturday ET

The Economist interviews President Donald Trump and spots the keyword *reciprocity* in many aspects of Trumponomics from trade and taxation to infrastructur
2025-09-14 14:23:00 Sunday ET

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund
2025-10-07 10:30:00 Tuesday ET

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund